Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Canada Lets Pfizer Amend Pregabalin Defense
Pharmascience Is Seeking Damages For Launch Delay
Oct 21 2019
•
By
Aidan Fry
Pfizer can amend its defense in a Canadian dispute over pregabalin • Source: Shutterstock
More from Legal & IP
More from Generics Bulletin